Imatinib Active Not Recruiting Phase 2 Trials for Cancer, Breast Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00338728Letrozole (Femara) Plus Imatinib Mesylate (Gleevec) for Breast Cancer Patients